Extending the diabetic retinopathy screening interval beyond 1 year: systematic review. - Test2 - elhamkhani - TriplyDB

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

http://www.wikidata.org/entity/Q36475523

about

Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities Stratifying the NHS Diabetic Eye Screening Programme: into the unknown?Biomarkers in Diabetic Retinopathy Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease [National guidelines for treatment of diabetic retinopathy : Second edition of the national guidelines for treatment of diabetic retinopathy].The Prevention and Treatment of Retinal Complications in Diabetes.Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients.Pathogenic roles of microvesicles in diabetic retinopathy.Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.Screening Intervals for Diabetic Retinopathy and Implications for Care.The incidence of diabetic retinopathy requiring treatment is also low in the under 90 age group.Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States.

P2860

Q28076765-72191CA7-FD1A-4B3C-AE32-5761DC31A049 Q28078692-02C0FEFB-E7AA-43C8-8EB7-76790646203C Q28338924-F1D26E6F-1EA5-4C99-A266-CADBBB556223 Q33583030-25EC2EEB-ABE0-4998-B505-834543F5A806 Q33705724-69ADBAAB-F7C6-4AAC-91E2-C8CF6ACBAD01 Q36063335-FE95F6CD-620D-4A70-8E1C-DBA2411D1711 Q36245823-13AA46B7-212B-4D87-B8AA-EF32455714FE Q38608819-280E9409-19A3-4F9F-B2A9-DD1605E992D0 Q38635273-4E84CCB7-139E-48AE-A7EC-2F0D683CBF6E Q38656787-F2A19848-240E-4C10-808F-B2D70CD9DFFA Q39867113-4013608E-A37C-4251-8126-C0A73DD19598 Q40502875-6F407891-F53C-440B-82D5-56FDC9FC4B44 Q40799284-2FA40508-95AF-4318-94E1-BE5F50D7D3D2 Q47553382-C09A5707-3B5B-4B20-AA2E-49B9297B7985

P2860

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

http://www.wikidata.org/entity/Q36475523

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@ast

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@en

type

label

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@ast

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@en

prefLabel

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@ast

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@en

P1433

Q36475523-7D43EBB2-F3DC-4FE6-AD48-7EC94ED46493

P1476

Q36475523-8845CC84-0BE4-4820-AC24-3B6E630FBA79

P2093

Q36475523-2C6A5802-FD7A-488F-91A4-7DF19B7E655E

Q36475523-58BBBA75-0751-4AEC-AC2F-7E6FB69AFE98

Q36475523-B855DDDC-E9FB-4BB0-97EB-B79F6471E50D

Q36475523-ED784159-C7A9-4CB9-8C97-E347903742CC

P275

Q36475523-E5D6ACE3-EB3C-41AF-93D4-E048EC9DA700

P2860

Q36475523-0FA653C8-16B2-4011-BFC0-11DAED4C3FB0

Q36475523-133C5C8E-A1BD-4A4F-AD2F-FA92A2DF4E18

Q36475523-1428C82F-A45B-4E5D-B595-DE69391BDBE7

Q36475523-27DE779F-1291-49F3-80C3-92A52ADB5F57

Q36475523-30D24D51-4B98-4B1C-BDEB-2F71927239C6

Q36475523-32C3E846-AFF3-41DF-B494-A7435FE79591

Q36475523-3FFEF655-CE26-4A79-801F-091F0380687C

Q36475523-4C5D58B7-3ED9-4141-9B92-04E26A3D8C81

Q36475523-4CD1FFAB-E84A-49C3-9372-E413405C3BCB

Q36475523-4CFDE320-E051-433A-8BF7-57DC1CA600A7

P304

Q36475523-0803350D-5D2F-4ACF-ADF3-C4EA4F408FBD

P31

Q36475523-9E24CF9F-A0D7-46EB-9CB0-FBCD3A9CA47A

Q36475523-AF5AE617-DE42-49EF-B049-68EF7C902C05

P356

Q36475523-54E21218-5FC1-4F64-A1CB-FDA0B3005985

P407

Q36475523-0C78026C-B0E7-4AE8-B845-1C04EAD016D8

P433

Q36475523-D83599C9-B970-4A05-85E3-257314E2D9A1

P478

Q36475523-C0BA303D-69A3-44CA-A58A-A18F203070C9

P50

Q36475523-7BC54921-2A83-4268-B783-F210FF8AEDBE

Q36475523-D1A52D53-A617-4970-B576-BF29B77A605A

Q36475523-E7F17284-DEC0-4257-BADF-1137187EE343

P5008

Q36475523-77BB967B-0906-4605-8915-6F49962503C2

P577

Q36475523-90A38BE8-0A2E-473D-80FD-1C41A05D37D8

Q36475523-BC15B733-FA8D-432E-A9CF-1F051FFFA14E

P5875

Q36475523-7F069A3F-585B-4477-97E6-25793F5A4B89

P698

Q36475523-03AA26D5-EA02-4EEA-AABA-422B75B74BAE

P921

Q36475523-AE055346-F1E5-40CB-976E-1B4DD5A671F7

Q36475523-B37841F3-073F-4C6B-9433-72C8251F7C54

Q36475523-CF00112C-DFB9-43C4-B3D3-17790E641B4F

Q36475523-D036FC4D-42CD-4063-A763-7E3284FF3400

P932

Q36475523-A0329F00-BA76-4B95-BF12-4E06B2F44ADF

P356

BJOPHTHALMOL-2014-305938

P1433

British Journal of Ophthalmology

P1476

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review.

@en

P2093

Alexander Tsertsvadze

http://www.w3.org/2001/XMLSchema#string

Dan Todkill

http://www.w3.org/2001/XMLSchema#string

Martin Connock

http://www.w3.org/2001/XMLSchema#string

Rachael Leslie

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

Screening and prevention of diabetic blindness.

Identification of independent risk factors for the development of diabetic retinopathy requiring treatment.

Detecting and treating retinopathy in patients with type I diabetes mellitus. A health policy model.

Adopting 3-year screening intervals for sight-threatening retinal vascular lesions in type 2 diabetic subjects without retinopathy.

Diabetic retinopathy--screening and management by Australian GPs.

Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?

Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

P304

105-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJOPHTHALMOL-2014-305938

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Sian Taylor-Phillips

P5008

P577

2015-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270965378

http://www.w3.org/2001/XMLSchema#string

P698

25586713

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

type-2 diabetes

diabetic retinopathy

maturity-onset diabetes of the young

P932

4717369

http://www.w3.org/2001/XMLSchema#string